US President Donald Trump introduced a large new commerce coverage on Thursday, declaring that the USA will impose tariffs of as much as 100 per cent on imported branded and patented pharmaceutical merchandise beginning October 1. The transfer is explicitly designed to power drug manufacturing again onto American soil and will have important repercussions for main international exporters, together with Indian drugmakers.
“Beginning October 1st, 2025, we might be imposing a 100% Tariff on any branded or patented Pharmaceutical Product, until a Firm IS BUILDING their Pharmaceutical Manufacturing Plant in America…” – President Donald J. Trump pic.twitter.com/z5EXQhw1xK
— The White Home (@WhiteHouse) September 25, 2025